Amneal Pharmaceuticals

Generic Drug Manufacturer

Based in NJ

🤖

AI Overview

With $450K in lobbying spend across 9 quarterly filings, Amneal Pharmaceuticals is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2022.

$450K
Total Spend
3
Years Active
1
Firms Hired
8
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$170K
2021$240K
2022$40K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Amneal Pharmaceuticals disclosed contacting in their lobbying filings.

Executive Office of the President (EOP)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy

Issues related to the generic drug industry

Biomedical Advanced Research and Development Authority, Pharmaceutical Manufacturing, Supply Chain

Pharmaceutical Manufacturing, Supply Chain, House GOP China Task Force

H.R. 938- BLOCKING Act of 2019

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.